IL1B and chronic obstructive pulmonary disease: In the further course of the disease, COPD is characterized by abnormal levels of inflammatory cytokines, such as the inflammatory master regulator IL-1β, and chemoattractants that trigger the recruitment of immune cells from the bloodstream into the lung (10–12).